Fund Card

Fund Card

ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)

As on Dec-02-2020 change fund
16.78  up0.15 (0.90%)

fund objective

To generate long-term capital appreciation by creating a portfolio that is invested in Equity and Equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.However there can be no assurance that the investment objectives of the scheme will be realized.

riskometer

Investors understand that their principal will be at high risk

5-Years History
financial year2018-20192019-2020
NAV in Rs (as on 31-Mar-2020)10.149.54
Net Assets(Rs Crores) (as on 31-Mar-2020) 1497.55 1073.47
Scheme Returns(%)(Absolute)1.40-6.38
B'mark Returns(%)(Absolute)6.85-15.95
Category Rank37/7315/75
Quarterly performance - Last 5 years (Absolute Ret. in %)
financial year Q1 Q2 Q3 Q4
2020-202137.1122.32NANA
2019-2020-4.93-2.399.88-7.74
2018-2019NANA-5.362.63
Top 10 holdings
company (%)
Cipla Ltd.9.54 
Sun Pharmaceutical Industries...9.35 
Alkem Laboratories Ltd.6.86 
Dr. Reddys Laboratories Ltd.5.00 
Divis Laboratories Ltd.4.76 
Tata Chemicals Ltd.4.73 
Ipca Laboratories Ltd.4.49 
Lupin Ltd.4.12 
Cadila Healthcare Ltd.3.52 
Sanofi India Ltd.3.14 

Category

Sector Funds

Launch Date

13-Jul-18

Scheme Benchmark

S&P BSE HEALTH CARE

AUM ( in Cr.)

1,961.72

portfolio price to book value

4.82

investing style?

Large Growth

fund manager?

Dharmesh Kakkad,Priyanka Khandelwal

inception date (regular plan)

13-Jul-18

expense ratio (regular plan) %

2.38

Alpha [%]

0.16

Beta [%]

0.47

Top 10 sectors
sectors (%)
Pharmaceuticals & Drugs72.12
Hospital & Healthcare Services6.13
Chemicals 4.92
Miscellaneous2.97
Insurance1.84
Unspecified0.06

Historical NAV Chart with Benchmark

to go
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • maximum
performance comparision with similar schemes
scheme name investment style inception date AUM in Cr. 1W(%) 1M(%) 3M(%) 1Y(%) 3Y(%) 5Y(%) 10Y(%) since inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Large-Growth 13-Jul-20181,961.724.357.8410.6162.28NANANA24.16BUYSIP
Nippon India Pharma Fund(G)Large-Growth 05-Jun-20043,899.683.499.2310.9759.2321.1010.4115.4321.26BUYSIP
Tata India Pharma & Healthcare Fund-Reg(G)Large-Growth 28-Dec-2015353.973.617.9211.2254.5418.70NANA7.56BUYSIP
UTI Healthcare Fund-Reg(G)Large-Growth 01-Aug-2005586.133.487.0410.0959.6916.457.6712.3718.50BUYSIP
SBI Healthcare Opp Fund-Reg(G)Large-Growth 14-Jul-19991,445.323.328.2411.1057.7614.044.9214.9815.57BUYSIP
DSP Healthcare Fund-Reg(G)Mid-Growth 30-Nov-2018890.493.527.1910.8371.86NANANA35.80BUYSIP
Mirae Asset Healthcare Fund-Reg(G)Large-Growth 02-Jul-20181,036.483.756.659.8765.81NANANA27.51BUYSIP
IDBI Healthcare Fund-Reg(G)Large-Growth 28-Feb-201960.333.546.567.8551.89NANANA30.90BUYSIP
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Large-Growth 10-Jul-2019418.003.237.637.2747.50NANANA37.70BUYSIP

Copyright © 2017 Vedant Asset. All Right Reserved.

Mutual Fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not an indicator of future returns. ARN-104974